COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP (SWOG) INNOVATIONS IN ADVANCED PROSTATE CANCER.

about

COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP (SWOG) INNOVATIONS IN ADVANCED PROSTATE CANCER.

Item

http://www.wikidata.org/entity/Q34309132

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

COOPERATIVE GROUP TRIALS - SOU ...... S IN ADVANCED PROSTATE CANCER.

@ast

COOPERATIVE GROUP TRIALS - SOU ...... S IN ADVANCED PROSTATE CANCER.

@en

COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP

@nl

type

Item

label

COOPERATIVE GROUP TRIALS - SOU ...... S IN ADVANCED PROSTATE CANCER.

@ast

COOPERATIVE GROUP TRIALS - SOU ...... S IN ADVANCED PROSTATE CANCER.

@en

COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP

@nl

prefLabel

COOPERATIVE GROUP TRIALS - SOU ...... S IN ADVANCED PROSTATE CANCER.

@ast

COOPERATIVE GROUP TRIALS - SOU ...... S IN ADVANCED PROSTATE CANCER.

@en

COOPERATIVE GROUP TRIALS - SOUTHWEST ONCOLOGY GROUP

@nl

P1476

COOPERATIVE GROUP TRIALS - SOU ...... S IN ADVANCED PROSTATE CANCER.

@en

P2093

Cathy M Tangen

http://www.w3.org/2001/XMLSchema#string

Celestia S Higano

http://www.w3.org/2001/XMLSchema#string

Daniel P Petrylak

http://www.w3.org/2001/XMLSchema#string

David I Quinn

http://www.w3.org/2001/XMLSchema#string

Derek Raghavan

http://www.w3.org/2001/XMLSchema#string

E David Crawford

http://www.w3.org/2001/XMLSchema#string

Ian M Thompson

http://www.w3.org/2001/XMLSchema#string

Maha H A Hussain

http://www.w3.org/2001/XMLSchema#string

Nicholas J Vogelzang

http://www.w3.org/2001/XMLSchema#string

Tanya B Dorff

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2009

The development of androgen-independent prostate cancer

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).

Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.

Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.

Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916

P304

69-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1758834009343454

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47812911

http://www.w3.org/2001/XMLSchema#string

P698

21085622

http://www.w3.org/2001/XMLSchema#string

P932

2981166

http://www.w3.org/2001/XMLSchema#string